AbbVie's Rinvoq shows potential for atopic dermatitis

19th June 2020 Uncategorised 0

The selective and reversible JAK inhibitor hit all goals in the Phase III Measure Up study

More: AbbVie's Rinvoq shows potential for atopic dermatitis
Source: News